EyePoint Pharmaceuticals Inc (EYPT)
15.93
-0.54
(-3.28%)
USD |
NASDAQ |
Apr 25, 12:13
EyePoint Pharmaceuticals Shareholders Equity (Quarterly): 266.32M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 266.32M |
September 30, 2023 | 58.62M |
June 30, 2023 | 57.26M |
March 31, 2023 | 78.39M |
December 31, 2022 | 96.37M |
September 30, 2022 | 136.35M |
June 30, 2022 | 151.37M |
March 31, 2022 | 166.82M |
December 31, 2021 | 184.38M |
September 30, 2021 | 92.75M |
June 30, 2021 | 106.86M |
March 31, 2021 | 115.71M |
December 31, 2020 | 18.54M |
September 30, 2020 | 7.594M |
June 30, 2020 | 4.188M |
March 31, 2020 | 16.47M |
December 31, 2019 | 8.33M |
September 30, 2019 | 15.94M |
June 30, 2019 | 28.21M |
March 31, 2019 | 19.88M |
September 30, 2018 | 47.70M |
June 30, 2018 | 11.69M |
March 31, 2018 | 8.198M |
December 31, 2017 | 9.905M |
September 30, 2017 | 9.001M |
Date | Value |
---|---|
June 30, 2017 | 13.34M |
March 31, 2017 | 12.51M |
December 31, 2016 | 14.76M |
September 30, 2016 | 14.45M |
June 30, 2016 | 20.88M |
March 31, 2016 | 26.55M |
December 31, 2015 | 14.42M |
September 30, 2015 | 18.82M |
June 30, 2015 | 23.37M |
March 31, 2015 | 27.85M |
December 31, 2014 | 32.28M |
September 30, 2014 | 35.80M |
June 30, 2014 | 14.92M |
March 31, 2014 | 18.35M |
December 31, 2013 | 12.60M |
September 30, 2013 | 14.24M |
June 30, 2013 | 7.70M |
March 31, 2013 | 11.24M |
December 31, 2012 | 13.81M |
September 30, 2012 | 16.16M |
June 30, 2012 | 13.64M |
March 31, 2012 | 15.56M |
December 31, 2011 | 17.79M |
September 30, 2011 | 35.23M |
June 30, 2011 | 37.43M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.188M
Minimum
Jun 2020
266.32M
Maximum
Dec 2023
84.76M
Average
78.39M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
INVO Bioscience Inc | 0.8928M |
Bio-Path Holdings Inc | 0.441M |
Ocular Therapeutix Inc | 91.13M |
Aileron Therapeutics Inc | 6.887M |
Apellis Pharmaceuticals Inc | 194.52M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 355.18M |
Total Liabilities (Quarterly) | 88.86M |
Current Ratio | 5.450 |
Net Debt Paydown Yield | 0.70% |